Text: S.2451 — 115th Congress (2017-2018)All Information (Except Text)

There is one version of the bill.

Text available as:

Shown Here:
Introduced in Senate (02/26/2018)


115th CONGRESS
2d Session
S. 2451


To require the Secretary of Health and Human Services to consider State analysis and sharing of prescription drug monitoring program data in determining prescription drug monitoring program grants to States.


IN THE SENATE OF THE UNITED STATES

February 26, 2018

Mr. Cassidy introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions


A BILL

To require the Secretary of Health and Human Services to consider State analysis and sharing of prescription drug monitoring program data in determining prescription drug monitoring program grants to States.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Protection from Overprescribing Act”.

SEC. 2. Consideration in awarding grants to support State PDMPs.

In determining whether to award a grant to a State in support of a State prescription drug monitoring program, the Secretary of Health and Human Services shall consider whether each agency of the State that administers the prescription drug monitoring program pro­ac­tively analyzes data available through the State’s prescription drug monitoring program and provides reports to law enforcement agencies, prescriber licensing boards, and other agencies describing any prescribers that repeatedly fall outside of expected norms or standard practices for the prescriber’s field.